For the quarter ending 2026-01-31, PURE made $444K in revenue. -$785K in net income. Net profit margin of -176.80%.
| Income Statement | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
| Total revenue | 444 | 708 | 632* | 491 |
| Cost of goods sold | 206 | 258 | 241* | 208 |
| Gross profit | 238 | 450 | 391* | 283 |
| Selling, general and administrative | 847 | 743 | 773* | 776 |
| Research and development | 74 | 86 | 73* | 91 |
| Total operating costs and expenses | 921 | 829 | 846* | 867 |
| Loss from operations | -683 | -379 | -455* | -584 |
| Other income (expense), net | -1 | 9 | -74* | 82 |
| Interest expense, net | 101 | 94 | -34* | 78 |
| Total other income (expense) | -102 | -85 | -40* | 4 |
| Net loss | -785 | -464 | -495 | -580 |
| Basic EPS | -0.01 | 0 | -0.004 | -0.01 |
| Diluted EPS | -0.01 | 0 | -0.004 | -0.01 |
| Basic Average Shares | 111,886,473 | 111,886,473 | 111,875,706 | 111,856,473 |
| Diluted Average Shares | 111,886,473 | 111,886,473 | 111,875,706 | 111,856,473 |
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)